A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R
NCT07513649 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-04-07
Summary
A study to evaluate the bioequivalence of DA-5230 compared to DA-5230-R
Conditions
- Healthy Adult Participants
Interventions
- DRUG
-
DA-5230
Test drug
- DRUG
-
DA-5230-R
Reference drug
Sponsors & Collaborators
-
Dong-A ST Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
More Related Trials
-
Bioequivalence of Ezetimibe Tablets in Healthy Subjects
NCT04814589 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects
NCT05481385 ·Status: UNKNOWN ·Phase: PHASE1
-
A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects
NCT06044233 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability
NCT00517543 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers
NCT06613139 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects
NCT05381870 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects
NCT06920719 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Seltorexant in Healthy Participants
NCT04553042 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study Between YHP2406 and YHR2501 in Healthy Subjects
NCT07265167 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Amphotericin B Liposome for Injection
NCT05913921 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects
NCT06168929 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Dotilavir Sodium Tablets in Healthy Subjects in the Fasting and Fed State
NCT05168176 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers
NCT06359626 ·Status: COMPLETED ·Phase: PHASE1
-
Phase1, Single Dose, Crossover Study to Determine Bioequivalence
NCT00786240 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Pharmacokinetics and Bioequivalence of HMPL-523 Tablets Produced by Two Different Manufacturers
NCT05318820 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions
NCT06823362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.
NCT01632449 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers
NCT02300688 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of CJ-30060 in Healthy Volunteers
NCT03757390 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects
NCT06926387 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers
NCT07128654 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers
NCT07470125 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Bioequivalence Study of Digoxin Tablet in Healthy Subjects
NCT06546215 ·Status: COMPLETED ·Phase: PHASE1
-
An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects
NCT01652859 ·Status: COMPLETED ·Phase: PHASE1
-
Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations
NCT02070796 ·Status: COMPLETED ·Phase: PHASE1